INTRODUCTION
It is widely agreed that the MAO inhibitor group of drugs are less effective anti-depressants than the tricydlics in severe depressions, specially those of endogenous type (Medical Research Council, 1965) , but a role for them is still claimed, for example, in the treatment of milder depressions or of depressive symptoms. According to Poldinger (1967) they are â€˜¿ therma gasics', i.e. psychic energizers or disinhibitors, and their mood elevating effect is relatively slight. Daily (1965) maintained that MAO inhibitors were most useful in atypical de pressions, with tension and anxiety, but were ineffective in patients with inadequate person alities. Kelly et al. (1970) found that these drugs relieved depressive symptoms in phobic anxiety states. In this paper we have attempted to re examine this question in a double-blind trial of pheneizine and amitriptyline in depressed out-patients.
PATIENTS AND METHOD
The 62 patients taking part were out-patients at two general hospitals. Some had recently been discharged from medical wards after treat ment for overdoses. All were defined as â€˜¿ re 
Early drop-out
Seventeen patients (27 per cent) dropped out early in the trial. These patients do not permit any conclusions to be drawn about the anti depressant efficacy of the drugs, and they have to be omitted from the one month assessments described below. It was noticed, however (Table I) 
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A DOUBLE-BLINDTRIAL OP PHENELZINE AND AMITRIPTYLINEIN DEPRESSEDOUT-PATIENTS tyline (i 3 v. 42 per cent), which is a significant difference, and is mainly due to a higher inci dence of unwanted effects in the latter.
T4@nu1I
Reasonfor earl, dropout differences in favour ofamitriptyline. But as the mean initial scores for both these scales are higher in the group receiving this drug, the change score difference might be partly due to initial score differences. Analyses of covariance were therefore carried out to adjust for this. The significance level of the Hamilton adjusted mean change score is the same as that for the change scores shown in Table II phenelzine for the kind ofpatients (i.e. depressed out-patients) who took part in the trial. This accords with the observation that during the next 3 months 9 of the 27 patients still taking phenelzine (33 per cent) but only 3 of the i8 still taking aniitriptyline (i 7 per cent) were removed from the trial owing to lack of progress (.io > P > .@5)
The means ofthe EPI N and E scores are also given in Table II . The mean change in neuro ticism score is significantly greater than zero in each drug group (in the phenelzine group P < 05, in amitriptyline group P < .001). When an analysis ofcovariance was carried out, for the same reasons as given above, the difference between the change scores was highly significant (F=8@2forIand39d.f.;P< @oi).Thusit may be concluded that amitriptyline decreases the N score more than phenelzine. The changes in E scores are not significant.
T@in II * P < @O5. Table II shows the mean scores on the Hamil ton, Beck and Lubin scales at the start of the trial and at one month, for those patients who com pleted the first month. The three mean change scores for each group on each depressive scale are all significantly greater than zero; both groups, therefore, improved during treatment.
Rating scales
The results oft-tests of the difference between the mean change scores of the two groups are also given in Table II . The mean Beck (P < .02) and Hamilton (P < . zo) change scores show Mean initial and one month scores, and mean change scores, on 5 rating scales in pheneizine and amifrip@ylinegroups t = P < .10;* = P < .o2;** = P < @oo5; P = Phenelzine; Am= Amitriptyline. 
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1)jj/Ã¨rentialeffect
To ascertain whether the treatment effects of the two drugs were related to different symptom patterns, the symptoms and other variables that were significantly (P < @O5) correlated with the Hamilton or Beck one month scores (or both), in the whole sample or in either of the two drug groups separately, were selected for study. â€˜¿ Subjective retardation', which was almost significantly correlated with the one month
Beck score in the pheneizine group, was in eluded, as was age. Table III shows the pattern ofthe correlations of these features with the Hamilton and Beck one month scores, together with the multiple correlations for each drug group and for the total sample. It will be noted that the multiple correlation for the total sample is less than that for either of the two drug groups, for both Hamilton and Beck scores. This suggests that a better prediction of outcome after one month of treatment is obtained by weighting the features for each drug separately. The pattern of corre lations also suggests that the two drugs act differentially on the variables studied.
Analyses of variance were then carried out (Rao, 1952) , to test whether the two drugs sets of regression coefficients are significantly different.
The F ratios obtained are both significant (F = 2 @ 3 @ d.f. = 8 and 27 for Hamilton score and F = 3 . @ 7 d.f. = i i and i 9 for Beck score), and it may be concluded that the effect of the two drugs on depression is dependent upon a differential action on the symptoms listed in Table III .
DiscussioN
The results show that more patients on amitriptyline than on pheneizine dropped out during the first month, but that among those who continued to take the drugs there was a trend for depressive symptoms to improve more with amitriptyline.
The most significant differ ence in favour of amitriptyline occurred, how ever, in the neuroticism (N) scores, which per sisted after allowing for initial score differences. It has been shown previously that N scores (of the MPI) decrease when depression improves (Coppen and Metcalfe,1965 ; Garside et a!., When the response of individual features was examined, it was noted that two features, the N score and ideas of reference, were significantly associated with poor response as measured by both the Hamilton and the Beck scales, while a high E (extraversion) score was a favourable sign on either one or other scale in both drug groups. Certain differences in the pattern of response of individual features were, however, found when the drug groups were compared. Ideas ofreference did not respond to either drug, but a high N score was definitely unfavourable only in the phenelzine treated group, which perhaps supports the view of Dally ( i 965) that â€˜¿ inadequatepersonalities' do not respond to this drug. Neurotic personality, clinically diagnosed, also tended to be associated with a poor phenelzine response. Of the other features, pyknic build, perhaps because ofits relationship to age, and subjective retardation, was also unfavourable, while blaming others was favour able on phenelzine but unfavourable on anti triptyline.
Four symptoms were correlated with outcome in the amitriptyline group only; irritability and depersonalization were unfavourable, and re sponsiveness of mood and evening accentuation favourable. It is interesting to find that these two The drop-out rate was significantly higher (P < .@5) in patients receiving amitriptyline than in those receiving phenelzine, mainly due to side effects. At one month, there was a trend on all three scales for patients still taking amitriptyline to have improved more than those still taking pheneizine, and the difference on the Beck scale was significant (P < .@), though it ceased to be so when a difference in the initial scores was taken into account. The change in EPI N scores, however, was significantly greater (P < . oi) in patients receiving amitriptyline even after allowing for the difference in initial scores, suggesting that the effect of this drug, in depressed out-patients, is due to an improvement in neurotic features as well as in depressive symptoms.
Evidence was found that, in the doses used, the response to the two drugs was related to a differential effect on individual features.
